Duramorph PF must be administered by a doctor in a hospital or clinical environment. It is typically intravenous (IV) or subcutaneous (SC) injection.
Administration Procedure:
- Preparation: Duramorph PF must be prepared in a sterile environment. Physicians will make sure that the injection site is free from germs and safe to use.
- Injection: The drug is injected into a vein or subcutaneously, as prescribed by the physician.
- Monitoring: The patient will be observed for respiratory depression, sedation, and other side effects after administration.
- Post-Administration Care: The patient will be closely observed for effectiveness of pain relief as well as side effects like dizziness or nausea.
Duramorph PF should only be administered in a controlled medical environment as abuse or misuse will lead to harmful side effects, even overdose.
Duramorph PF does this by binding to certain receptors in the brain and spinal cord, or opioid receptors, of the nervous system. These receptors are used in the sensing of pain. When Duramorph PF is administered by injection, it lowers the level of pain by altering the manner in which the body perceives and reacts to pain stimuli.
- Side Effects of Duramorph
Since Duramorph PF is similar to any opioid, there may be side effects to the drug. Some of the common side effects are:
- Somnolence or drowsiness
- Nausea or vomiting
- Constipation
- Dizziness
- Sweating
- Pruritus or rash
Severe Side Effects
- Respiratory Depression: Slow or shallow breathing is among the very serious side effects of opioid drugs such as Duramorph PF, which, if not treated, can be lethal.
- Addiction: Physical dependency and addiction result from repeated administration of Duramorph PF.
- Hypotension (Low Blood Pressure): Opioids lower blood pressure, leading to dizziness and fainting.
- Overdose: Overdosage or misuse of Duramorph PF causes overdose, which is harmful and even lethal. Its signs and symptoms are sleepiness to a profound degree, respiratory depression, loss of consciousness, and clammy and cold skin.
Notify immediately to a healthcare provider for any serious side effects.
There are some warnings and precautions with the administration of Duramorph PF as follows:
- Risk of Abuse and Addiction: Duramorph PF is an opioid, and like all opioids, it has a risk for abuse, addiction, and misuse, with resultant overdose and death.
- Respiratory Depression: The biggest risk of Duramorph PF is respiratory depression, which is fatal. It’s particularly hazardous for patients who have respiratory disease like asthma or chronic obstructive pulmonary disease (COPD).
- Liver or Kidney Disease: Liver or kidney disease must be managed with caution using Duramorph PF since metabolism and excretion of the drug may be impaired in liver or kidney diseases.
- Pregnancy and Breastfeeding: Pregnancy must only be done if it is advantageous compared to being harmful. Pregnancy must not be initiated while lactation is ongoing because it will pass into the breast milk and harm the baby.
- Geriatric Patients: Geriatric patients are most likely to be tolerant to the side effects of the opioids, including dizziness, confusion, and sedation.
The dosage of Duramorph PF varies with the severity of pain, patient’s medical history, and opioid tolerance:
- Initial Dosage: The dose to be initiated is generally 2-10 mg intravenously or subcutaneously and is to be repeated every 4 hours on an as needed basis.
- Titration: Gradually steps in dose levels can be used to deal with pain relief requirements, but always with medical guidance.
- Patient Monitoring: Monitoring needs to be continued at all times while administering Duramorph PF as an excessive dose has the ability to bring forth severe side effects.